Department of Pharmaceutics, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Curr Drug Deliv. 2021;18(8):1125-1135. doi: 10.2174/1567201818666210204164145.
Metformin Hydrochloride (MH) is an oral anti-hyperglycemic agent belonging to the biguanide class of drugs.
The present study involves the formulation and evaluation of gastro-retentive floating microparticles containing MH as a model drug for the prolongation of absorption time.
Three levels of a three-factor, Box-Behnken design were used to evaluate the critical formulation variables. Microparticles were prepared using a water-in-oil-in-water double-emulsion solvent evaporation method and examined in terms of production yield, particle size, entrapment efficiency, floating ability, morphology, FTIR (Fourier transform infrared spectroscopy), and in vitro drug release.
The optimum conditions for preparing MH microparticles were predicted to be the content of ethyl cellulose content (150 mg),poly (ε-caprolactone) (150 mg), and polyvinyl alcohol (1%w/v).The optimized MH microparticles were found to be spherical with a mean size of 350.2 µm. Entrapment efficiency was 58.62% for microparticles. 63.94% of microparticles showed floating properties. The FTIR analysis confirmed no chemical linkage between microparticle components. in vitro release study showed a controlled release for up to 8h.
These results demonstrated that MH microparticles, as a drug delivery system, may be useful to achieve a controlled drug release profile suitable for oral administration and may help to reduce the dose of the drug and to improve patient compliance.
盐酸二甲双胍(MH)是一种属于双胍类药物的口服抗高血糖药物。
本研究涉及含有 MH 的胃滞留漂浮微球的配方和评价,作为延长吸收时间的模型药物。
采用三因素三水平 Box-Behnken 设计来评估关键制剂变量。使用水包油包水双乳液溶剂蒸发法制备微球,并考察其产率、粒径、包封效率、漂浮能力、形态、FTIR(傅里叶变换红外光谱)和体外药物释放。
制备 MH 微球的最佳条件预测为乙基纤维素含量(150mg)、聚(ε-己内酯)(150mg)和聚乙烯醇(1%w/v)。优化的 MH 微球呈球形,平均粒径为 350.2μm。微球的包封效率为 58.62%。63.94%的微球具有漂浮性能。FTIR 分析证实微球成分之间没有化学结合。体外释放研究表明,微球在 8 小时内可实现控制释放。
这些结果表明,作为一种药物传递系统,MH 微球可能有助于实现适合口服给药的控释药物释放特征,有助于减少药物剂量并提高患者的顺应性。